Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children?

Neoplasma

Volumn 45, Issue 3, 1998, Pages 135-139

  Cap J ^a   Foltinova A ^a   Kaiserova E ^a   Babusikova O ^b   Jamarik M ^a   Jasenkova M ^a  

^a University Children's Hospital   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Childhood leukemia; High risk leukemia; Immunophenotyping; T cell ALL

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CELL MATURATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; MALE; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SURVIVAL TIME; T CELL LEUKEMIA;

EID: 0031844748     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ARICO, M., BASSO, G., MANDELLI, F., RIZZARI, C., COLELLA, R., BARISONE, E., ZANESEO, L.,RONDELLI, R., PESSION, A., MASERA, G.: Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. Cancer, 75, 1995, 1684-1693.
2. BABUŠÍKOVA, O., HRIVŇĀKOVĀ, A.,ČÁP, J., UJHAZY, P.: Diagnosis and analysis of T phenotype acute lymphoblastic leukemia. Neoplasma, 35, 1988, 661-666.
3. BABUSIKOVA, O., ČĀP, J., HRIVŇĀKOVÁ, A., KLOBUŠICKÁ, M., MESÁROŠOVÁ, A., KONIKOVÁ, E.: Purine metabolism enzyme pattern, cytochemical characteristics and clinical pathological features of CDIO positive childhood T cell leukemia. Neoplasma, 38, 1991, 595-602.
4. BABUŠÍKOVÁ, O., MESÁROŠOVÁ, A., KONİKOVÁ, E., KUSENDA, J., GLASOVÁ, M., KLOBUŠICKA, M.: Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Neoplasma, 40, 1993, 275-281.
5. ČÁP, J., FOLTINOVA, A., MIŠİKOVÁ, Ž., KAISEROVÁ, E., ŠTRBÁKOVÁ, E., BUBÁNSKA, E., ORAVKINOVA, I., HALÁKOVA, E.: Two decades of treatment of children with acute lymphoblastic leukemia in Slovakia. Českoslov. pediatr., 51, 1996, 63-69 (In Slovak.)
6. ČAP, J., FOLTINOVÁ, A., KAISEROVÁ, E., MOJZEŠOVÁ, A., SEJNOVÁ, D., JAMÁRIK, M.: Is high dose methotrexate without the brain irradiation sufficiently effective in prevention of CNS disease in children with acute lymphoblastic leukemia? Neoplasma, 45, 1998, 176-179.
7. CRIST, W.M., SHUSTER, J.J., FALLETTA, J., PULLEN, D.J., BERARD, C.W., VIETTI, T.J., ALVARADO, C.S., ROPER, M.A., PRASTHOFER, E., GROSSI, C.E.: Clinical features and outcome in childhood T-cell leukemia-lymphoma. According to stage of thymocyte differentiation. Blood, 72 , 1988, 1891-1897.
8. DIBENEDETTO, S.P., LO NIGRO, L., MAYER, S.P., ROVERA, G., SCHILLIRO, G.: Detectable molecular residual disease at the beginning of maintenance indicates poor outcome in children with T-cell acute lymphoblastic leukemia. Blood, 90, 1997, 1226-32.
9. GLASOVÁ, M., KONÍKDVÁ, E., KUSENDA, J., BABUŠIKOVÁ, O.: Evaluation of different fixation methods for simultaneous detection of surface, cytoplasmic markers and DNA analysis by flow cytometry in some human hematopoietic cell lines. Neoplasma, 42, 1995, 337-346.
10. POPLACK, D.G.: Acute lymphoblastic leukemia. In: Principles and Practice of Pediatric Oncology. Eds: Pizzo, P.A., Poplack, D.G. Philadelphia, J.B.Lippincott 1993, 431-482.
11. PUI, C.H., BEHM, F.G., SINGH, B., SCHEL I, M.J., WILLIAMS, D.L., RIVERA, G.K. KALWINSKY, D.K., SANDLUND, J.T., CRIST, W.M., RAIMONDI, S.C.: Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood, 75, 1990, 174-179.
12. PUI, C.H., BEHM, F.G., CRIST, W.M.: Clinical and biologic relevance of immunologic markers studies in childhood acute lymphoblastic leukemia. Blood, 82, 1993, 342-362.
13. PUI, C.H., CRIST, W.M.: Biology and treatment of acute lymphoblastic leukemia, J. Pediatr., 124, 1994, 491-503.
14. RAJALEKSHMY, K.R., ABITHA, A.R., PRAMILA, R., GNANASAGAR, T., SAHNTA, V: Immunophenotypic analysis of T-cell acute lymphoblastic leukemia in Madras, India. Leuk. Res., 21, 1997, 119-124.
15. RHIEM, H., GADNER, H., HENZE, G., KORNHUBER, B., LAMPERT, F., NIETHAMMER, D., REITER, H., SCHELLONG, G.: Results and significance of six randomised trials in four consecutive ALL-BFM studies. Hematol. Blood Transfusion, 33, 1990, 439-450.
16. SCHRAPPE, M., REITER, A., SAUTER, S., LUDWIG, W.D., WǑRMANN, B., HARBOTT, J., BENDER-GOTZE, C., DORFFEL, W., DOPFER, R., FREY, E., HAVERS, W , HENZE, G., KǓHL, J., RICHTER, R, RITTER, J., TREUNER, J., ZINTL, F., ODENWALD, E., WELTE, K., RIEHM, H.: Konzeption und Zwischenergebnis der Therapie-studie ALL-BFM-90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens im Blut und Knochenmark. Klin. Pädiat., 206, 1994, 208-221.
17. SHUSTER, J.J., FALLETTA, J.M., PULLEN, J., CRIST, W.M., HUMPHREY, G.B., DOWELL, B.L., WHARAM, M.D., BOROWITZ, M.: Prognostic factors in childhood T-cell acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood, 75, 1990, 166-173.
18. Therapiestudie ALL-BFM-95. Multizentrische kooperative Therapiestudie zur Behandlung von Kindern und Jugendlichen mit akuter lymphoblastischen Leukämie. Studienleiter Prof. Dr. Dr.h.c. H.Riehm. Hannover, Medizinische Hochschule Hannover 1995, 105.
19. UCKUN, F.M., REAMAN, G., STEINHERZ, P.G., ARTHUR, D.C., SATHERM, H., TRIGG, M., GAYNON, P.: Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Childrens Cancer Group Study. Leuk. Lymphoma, 24, 1996, 57-70.
20. UCKUN, F.M., GAYON, P.S., SENSEL, M.G., NACHMAN, J., TRIGG, M.E., STEINHERZ, P.G., HUTCHINSON, R., BOSTROM, B.C., SATHER, H.N., REAMAN, G.H.: Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: A Children's Cancer Group Study. J. Clin. Oncol., 15, 1997, 2214-2221.